Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-011790
Filing Date
2025-05-20
Accepted
2025-05-20 17:20:40
Documents
46
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 638177
2 EX-31.1 ex31-1.htm EX-31.1 9476
3 EX-32.1 ex32-1.htm EX-32.1 4179
  Complete submission text file 0001641172-25-011790.txt   3685432

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ftii-20250331.xsd EX-101.SCH 31595
5 XBRL CALCULATION FILE ftii-20250331_cal.xml EX-101.CAL 34082
6 XBRL DEFINITION FILE ftii-20250331_def.xml EX-101.DEF 190793
7 XBRL LABEL FILE ftii-20250331_lab.xml EX-101.LAB 236004
8 XBRL PRESENTATION FILE ftii-20250331_pre.xml EX-101.PRE 213182
48 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 454230
Mailing Address 128 GAIL DRIVE NEW ROCHELLE NY 10805
Business Address 128 GAIL DRIVE NEW ROCHELLE NY 10805 9143164805
FutureTech II Acquisition Corp. (Filer) CIK: 0001889450 (see all company filings)

EIN.: 872551539 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41289 | Film No.: 25970038
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)